Mitochondrial localization and pro-apoptotic effects of the interferon-inducible protein ISG12a

被引:95
作者
Rosebeck, Shaun [1 ]
Leaman, Douglas W. [1 ]
机构
[1] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA
关键词
apoptosis; caspases; membrane potential; Bcl-2; Bax;
D O I
10.1007/s10495-008-0190-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ISG12a is one of the most highly induced genes following treatment of cells with type I interferons (IFNs). The encoded protein belongs to a family of poorly characterized, low molecular weight IFN-inducible proteins that includes 6-16 (G1P3), 1-8U (IFITM3), and 1-8D (IFITM2). Our studies demonstrate that the ISG12a protein associates with or inserts into the mitochondrial membrane. Transient expression of ISG12a led to decreased viable cell numbers and enhanced sensitivity to DNA-damage induced apoptosis, effects that were blocked by Bcl-2 co-expression or treatment with a pan-caspase inhibitor. ISG12a enhanced etoposide induced cytochrome c release, Bax activation and loss of mitochondrial membrane potential. siRNA-mediated inhibition of ectopic ISG12a protein expression prevented the sensitization to etoposide-induced apoptosis and also decreased the ability of IFN-beta pretreatment to sensitize cells to etoposide, thereby demonstrating a role for ISG12a in this process. These data suggest that ISG12a contributes to IFN-dependent perturbation of normal mitochondrial function, thus adding ISG12a to a growing list of IFN-induced proteins that impact cellular apoptosis.
引用
收藏
页码:562 / 572
页数:11
相关论文
共 53 条
  • [1] Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/caspase-8 death signaling pathway
    Balachandran, S
    Roberts, PC
    Kipperman, T
    Bhalla, KN
    Compans, RW
    Archer, DR
    Barber, GN
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (03) : 1513 - 1523
  • [2] Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling
    Balachandran, S
    Kim, CN
    Yeh, WC
    Mak, TW
    Bhalla, K
    Barber, GN
    [J]. EMBO JOURNAL, 1998, 17 (23) : 6888 - 6902
  • [3] Bani MR, 2004, MOL CANCER THER, V3, P111
  • [4] Borden, 1998, Oncologist, V3, P198
  • [5] BUDHU A, 2007, IN PRESS CARCINOGENE
  • [6] Chawla-Sarkar M, 2001, CLIN CANCER RES, V7, P1821
  • [7] IFN-β pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis
    Chawla-Sarkar, M
    Leaman, DW
    Jacobs, BS
    Borden, EC
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (02) : 847 - 855
  • [8] Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosis
    Chawla-Sarkar, M
    Lindner, DJ
    Liu, YF
    Williams, B
    Sen, GC
    Silverman, RH
    Borden, EC
    [J]. APOPTOSIS, 2003, 8 (03) : 237 - 249
  • [9] CHEN Q, 1998, BLOOD, V123, P2183
  • [10] G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells
    Cheriyath, Venugopalan
    Glaser, Keith B.
    Waring, Jeffrey F.
    Baz, Rachid
    Hussein, Mohamad A.
    Borden, Ernest C.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (10) : 3107 - 3117